We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $638M Turnover 12.86%
1-Year Est. Return 30.27%
This Fund
S&P 500
This Quarter Est. Return
+18.61%
1 Year Est. Return
+30.27%
3 Year Est. Return
+136.79%
5 Year Est. Return
+207.15%
10 Year Est. Return
+579.03%
AUM
$680M
AUM Growth
+$12.5M
Cap. Flow
-$83.6M
Cap. Flow %
-12.28%
Top 10 Hldgs %
19.1%
Holding
216
New
16
Increased
34
Reduced
132
Closed
17
Avg Time Held Equity + Options
3 years
Top 10 Avg Time Held Equity + Options
1.3 years
Top 20 Avg Time Held Equity + Options
1.3 years
Avg Time Held Equity only
3.1 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.3 years

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.52M
2
NRG icon
NRG Energy
NRG
+$6.36M
3
SNX icon
TD Synnex
SNX
+$5.16M
4
SYK icon
Stryker
SYK
+$3.97M
5
DE icon
Deere & Co
DE
+$3.68M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.62M
2
CRM icon
Salesforce
CRM
+$5.9M
3
EL icon
Estee Lauder
EL
+$5M
4
SANM icon
Sanmina
SANM
+$3.63M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.59M

Sector Composition

Rank Sector Weight
1 Financials 16.71%
2 Industrials 16.07%
3 Technology 15.33%
4 Miscellaneous 11.59%
5 Healthcare 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PM icon
1
Philip Morris
PM
$311B
$15M 2.21%
83,152
+11,751
+16% +$2.04M
2016 Q2
40 quarters
GEV icon
2
GE Vernova
GEV
$247B
$15M 2.21%
12,804
-2,901
-18% -$2.96M
2024 Q2
8 quarters
CVS icon
3
CVS Health
CVS
$118B
$13.9M 2.05%
134,539
+28,052
+26% +$2.5M
2025 Q3
3 quarters
GE icon
4
GE Aerospace
GE
$323B
$13.1M 1.93%
35,051
-564
-2% -$177K
2023 Q4
10 quarters
C icon
5
Citigroup
C
$206B
$13M 1.9%
92,597
-24,110
-21% -$3.14M
2022 Q3
15 quarters
TSM icon
6
TSMC
TSM
$2.19T
$12.9M 1.9%
27,023
-718
-3% -$291K
2023 Q1
13 quarters
MS icon
7
Morgan Stanley
MS
$286B
$12.7M 1.86%
60,635
-14,408
-19% -$2.85M
2020 Q1
25 quarters
GLD icon
8
SPDR Gold Trust
GLD
$141B
$12.6M 1.85%
34,108
+685
+2% +$284K
2020 Q2
24 quarters
NXPI icon
9
NXP Semiconductors
NXPI
$58.3B
$11.5M 1.69%
40,899
+2,447
+6% +$674K
2025 Q3
3 quarters
MKSI icon
10
MKS Inc
MKSI
$15.5B
$10.3M 1.51%
23,048
+621
+3% +$194K
2025 Q4
2 quarters
TEL icon
11
TE Connectivity
TEL
$61B
$10.1M 1.49%
50,285
+12,783
+34% +$2.72M
2025 Q2
4 quarters
ETR icon
12
Entergy
ETR
$49.5B
$9.93M 1.46%
86,448
-5,226
-6% -$589K
2024 Q2
8 quarters
RS icon
13
Reliance Steel & Aluminium
RS
$20.8B
$9.56M 1.41%
25,588
-1,049
-4% -$384K
2018 Q1
33 quarters
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.27T
$9.19M 1.35%
25,715
-227
-0.9% -$81.7K
2019 Q3
27 quarters
CSCO icon
15
Cisco
CSCO
$432B
$9.14M 1.34%
77,778
-1,052
-1% -$110K
2025 Q2
4 quarters
SANM icon
16
Sanmina
SANM
$10B
$8.72M 1.28%
34,464
-16,554
-32% -$3.63M
2025 Q2
4 quarters
FCX icon
17
Freeport-McMoran
FCX
$101B
$8.71M 1.28%
138,481
-32,499
-19% -$2.09M
2020 Q4
22 quarters
PH icon
18
Parker-Hannifin
PH
$121B
$8.7M 1.28%
8,897
-140
-2% -$128K
2026 Q1
1 quarter
COF icon
19
Capital One
COF
$123B
$8.7M 1.28%
43,376
-5,310
-11% -$1.02M
2023 Q4
10 quarters
JLL icon
20
Jones Lang LaSalle
JLL
$14.2B
$8.7M 1.28%
28,072
+341
+1% +$106K
2024 Q3
7 quarters
BKR icon
21
Baker Hughes
BKR
$53.4B
$8.7M 1.28%
156,744
+1,273
+0.8% +$80.5K
2023 Q1
13 quarters
RL icon
22
Ralph Lauren
RL
$23.4B
$8.69M 1.28%
21,659
-282
-1% -$105K
2025 Q2
4 quarters
AZN icon
23
AstraZeneca
AZN
$260B
$8.52M 1.25%
+45,272
New +$8.52M
2026 Q2
0 quarters
WFC icon
24
Wells Fargo
WFC
$249B
$8.26M 1.21%
99,896
-753
-0.7% -$60.5K
2021 Q2
20 quarters
ABBV icon
25
AbbVie
ABBV
$504B
$7.92M 1.16%
31,485
-2,145
-6% -$461K
2020 Q1
25 quarters

Similar funds

Oliver Luxxe Assets's Q2 2026 Portfolio in Review

As of Q2 2026, Oliver Luxxe Assets held 216 positions worth $680M, up 1.9% from $668M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oliver Luxxe Assets withdrew a net $83.6M in Q2 2026, closing 17 positions and reducing 132 holdings. Its most notable exit was HCA Healthcare, an estimated $6.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Oliver Luxxe Assets opened a new position in AstraZeneca worth $8.52M.

  • Oliver Luxxe Assets's largest Q2 2026 buy was AstraZeneca: 45,272 shares worth $8.52M.
  • Oliver Luxxe Assets added most to TE Connectivity in Q2 2026, an estimated $2.72M increase.
  • Oliver Luxxe Assets's biggest Q2 2026 reduction was Sanmina, cutting an estimated $3.63M.
  • Oliver Luxxe Assets fully exited HCA Healthcare in Q2 2026, selling an estimated $6.62M.
  • Oliver Luxxe Assets's ten largest holdings make up 19% of its $680M portfolio in Q2 2026.
  • Oliver Luxxe Assets opened 16 new positions and closed 17 in Q2 2026.
  • Oliver Luxxe Assets's portfolio value rose 1.9% quarter-over-quarter to $680M.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.